Here at Crowdability, Wayne and I like to keep a low profile.

For the last five years, we’ve just been quietly teaching ordinary investors like you how to make a fortune by investing in start-ups.

The professional investors in Silicon Valley don’t like that we’re encroaching on their turf. (As…

In 1884, despite serious reservations, a 47-year-old man named Samuel L. Clemens climbed onto a bicycle for the first time.

He soon announced his verdict:

“Get a bicycle,” he urged. “You will not regret it, if you live.”

Clemens was the pen name for Mark Twain, and over the next…

When Wayne and I first decided to start Crowdability nearly five years ago, we ran the idea past a bunch of our Venture Capitalist (“VC”) friends.

As we explained, our goal was to teach everyone how to make money investing in start-ups.

Surprisingly, most of these VCs came back to…

In a 2011 Huffington Post article, the author explained why the “best and brightest” college graduates were heading to Wall Street:

“It’s basic human nature,” she wrote. “Follow the money.”

Makes sense. After all, according to Investopedia, in 2016, the average Goldman Sachs employee took home $367,564.

But in the…

Although most cryptos have experienced a pullback over the past few weeks, one corner of the crypto market continues to shine: ICOs.

ICOs, short for Initial Coin Offerings, continue to be one of the most profitable ways to invest in crypto-currencies.

For instance, while Bitcoin is down by about 50%…

At Crowdability, Wayne and I help you earn big gains from exciting investments like start-ups and crypto-currencies.

But we also do something else:

We aim to protect you — especially by helping you steer clear of investments that are “too good to be true” or downright scams.

So today, I’d…

Investing in biotech companies has made a lot of people very wealthy.

And it’s easy to see why:

Over the years, shares of big names like Merck have skyrocketed from just a dollar or two to $60 or more.

And meanwhile, recent IPOs for young biotech companies like Clovis, Nektar,…

For the last twenty years, Wayne and I have been “hooked” on investing in pre-IPO start-ups.

We still invest in traditional assets like stocks, bonds, and real estate...

But investing in start-ups gives us something extra — something other investments can’t.

Part of the “addiction” is the market-beating returns. But…

Here’s a riddle for you:

What do robots, craft beer, and med-tech devices have in common?

Ready for the answer?

They’re all made by start-up companies you can invest in right now.

But I’m not here today to tell you about beer or robot start-ups…

Instead, I’m here to tell…

Do you believe in second chances?

We sure do — and after reading this article, we think you might, too.

You see, cryptos are back!

In 2017, the average gain of the top-20 cryptos was 81,453%. That’s enough to turn $1,000 into more than $800,000.

But then the crypto market…